Immunohistochemical Characteristics of Low-Risk (Grade-II) and High-Risk (Grade-III) Astrocytomas
Keywords:
glioma, astrocytoma, proliferative activity (Ki-67), vascular endothelial growth factor
Abstract
An immunohistochemical study of astrocytomas of neuroepithelial tumors, which differ from each other in terms of their degree of malignancy, was conducted using the following monoclonal antibodies: VGFR (vascular endothelial growth factor), Ki67 (proliferation marker), Bcl 2 (antiapoptotic factor), p53- (suppressor protein) and glial. immunohistochemical characteristics were analyzed in astrocytomas.
References
1. A.A. Zrelov, A. Yu. Ulitin, M.V. Matsko... "Morfologicheskie i mokulyarno-geneticheskie osobennosti hemistotsitarnxx astrocytoma" sbornik nauchnyx rabot III peterburgskogo international onkologicheskogo forum "Belye nochi 2017" g. St. Petersburg
2. Gawdi R., Gawdi R., Emmady PD. Blood Brain Barrier Physiology. StatPearls. Treasure Island (FL) StatPearls Publishing. 2020;13:1123–1131.
3. Louis D.N., Ohgaki H., Wiesler O.D., Cavenee W.K., et al. al. WHO Classification of Tumors of the Central Nervous System. – IARC: Lyon, 2007.
4. Matsko, D.E. Classification of central nervous system tumors WHO (2016) / D.E. Matsko, M.V. Matsko // Rossiyskiy neurokhirurgicheskiy zurnal im. Professor AL Polenova. - 2016. - T. 8. – no. 4. – S. 5-11.
5. Matsko D.E., Korshunov A.G. Atlas of tumors of the central nervous system: (Histological structure). SPb.: SPb. RNAi im. Polenova.
6. Zhukova T.V, Shanko Yu.G. Pathomorfologicheskaya otsenka peritumoroznoy zony vysokozlokachestvennyx glioma kak kriteriy minimizatsii volume operativno vmeshatelstva. "Neurology and neurosurgery. Vostochnaya Evropa», 2022, volume 12, number 1
7. Paltsev M.A., Frank G.A., Malkov P.G. Standartnye tekhnologicheskie protsedury primorfologicheskom issledovanii biopsiynogo i operatsionnogo materiala. Archive pathology. 2011g.
8. Korshunov, A.G. Prognosticheskoe znachenie onkoassotsiirovannyx belkov and apoptosis v glioblastomax bolshikh polushariy holovnogo mozga / A.G. Korshunov, A.V. Golanov, R.V. Sycheva, I.N. Pronin // Vopr. neurosurgery. – 1999. – no. 1. – S. 3-7.
9. Milyukov, S.M. Diagnosis and treatment of primary infiltrative glioma with low level of malignancy / S.M. Milyukov // Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii. - 2016. - T. 16. – no. 2.
10. Lisyanyi N.I "Disruption of apoptotic processes in glioma brain" 2004.
11. Kolotov K.A. "Immunogistokhimicheskie osobennosti glialnyx tumor of the brain" 2012 g.
12. Kazarova M.V. "The role of prognostic factors in the selection of options for post-operative therapy in combined and complex treatment of primary anaplastic glioma of the brain" 2016.
13. O.M. Vorobeva "The phenomenon of pseudotumorous cross-immunohistochemical reactivity of glial in progressive multifocal leukoencephalopathy" 2022.
14. Chernov A.N., Galimova E.S., Shamova O.V. Molecular mechanism of medical resistance of glial tumor brain. Chast 2. Proliferation, angiogenesis, metastasis and retsidivirovanie // Meditsinskiy akademicheskiy zhurl. 2022. T. 22. No. 1. S. 89–117.
2. Gawdi R., Gawdi R., Emmady PD. Blood Brain Barrier Physiology. StatPearls. Treasure Island (FL) StatPearls Publishing. 2020;13:1123–1131.
3. Louis D.N., Ohgaki H., Wiesler O.D., Cavenee W.K., et al. al. WHO Classification of Tumors of the Central Nervous System. – IARC: Lyon, 2007.
4. Matsko, D.E. Classification of central nervous system tumors WHO (2016) / D.E. Matsko, M.V. Matsko // Rossiyskiy neurokhirurgicheskiy zurnal im. Professor AL Polenova. - 2016. - T. 8. – no. 4. – S. 5-11.
5. Matsko D.E., Korshunov A.G. Atlas of tumors of the central nervous system: (Histological structure). SPb.: SPb. RNAi im. Polenova.
6. Zhukova T.V, Shanko Yu.G. Pathomorfologicheskaya otsenka peritumoroznoy zony vysokozlokachestvennyx glioma kak kriteriy minimizatsii volume operativno vmeshatelstva. "Neurology and neurosurgery. Vostochnaya Evropa», 2022, volume 12, number 1
7. Paltsev M.A., Frank G.A., Malkov P.G. Standartnye tekhnologicheskie protsedury primorfologicheskom issledovanii biopsiynogo i operatsionnogo materiala. Archive pathology. 2011g.
8. Korshunov, A.G. Prognosticheskoe znachenie onkoassotsiirovannyx belkov and apoptosis v glioblastomax bolshikh polushariy holovnogo mozga / A.G. Korshunov, A.V. Golanov, R.V. Sycheva, I.N. Pronin // Vopr. neurosurgery. – 1999. – no. 1. – S. 3-7.
9. Milyukov, S.M. Diagnosis and treatment of primary infiltrative glioma with low level of malignancy / S.M. Milyukov // Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii. - 2016. - T. 16. – no. 2.
10. Lisyanyi N.I "Disruption of apoptotic processes in glioma brain" 2004.
11. Kolotov K.A. "Immunogistokhimicheskie osobennosti glialnyx tumor of the brain" 2012 g.
12. Kazarova M.V. "The role of prognostic factors in the selection of options for post-operative therapy in combined and complex treatment of primary anaplastic glioma of the brain" 2016.
13. O.M. Vorobeva "The phenomenon of pseudotumorous cross-immunohistochemical reactivity of glial in progressive multifocal leukoencephalopathy" 2022.
14. Chernov A.N., Galimova E.S., Shamova O.V. Molecular mechanism of medical resistance of glial tumor brain. Chast 2. Proliferation, angiogenesis, metastasis and retsidivirovanie // Meditsinskiy akademicheskiy zhurl. 2022. T. 22. No. 1. S. 89–117.
Published
2023-10-26
How to Cite
H. J. Beknazarov, X. A. Rasulov., & D. A. Nishanov. (2023). Immunohistochemical Characteristics of Low-Risk (Grade-II) and High-Risk (Grade-III) Astrocytomas. Central Asian Journal of Medical and Natural Science, 4(5), 860-864. Retrieved from https://www.cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1933
Section
Articles
